Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation
Pharmacoepidemiology and Drug Safety · 2024
DOI: 10.1002/pds.70063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Takayuki Anno und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Hematoma, Subdural, Chronic, Anticoagulants, Recurrence. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Purpose
Clinicians treating patients with atrial fibrillation (AF) on oral anticoagulants who undergo surgery for chronic subdural hematoma (CSDH) face a dilemma: while early postoperative resumption of anticoagulation is necessary to prevent embolism, it may increase the risk of CSDH recurrence. To date, however, no study has evaluated this question while adequately addressing common biases in observational studies. Here, we assessed this issue using target trial emulation framework.
Methods
We identified patients undergoing initial CSDH surgery who had received anticoagulation for AF preoperatively from two hospital‐based administrative databases (2014–2022). We compared two treatment strategies: resumption of anticoagulation within 14 days postoperatively versus no resumption during this period. Using a three‐step method of cloning, censoring, and weighting, we estimated the risk of CSDH recurrence, along with the risk ratio and risk difference at postoperative day 90.
Results
291 CSDH patients with AF were eligible, of whom 29 (10.0%) underwent CSDH reoperation. The weighted estimated 90‐day reoperation risk was 11.7% (95% confidence interval [CI], 6.0 to 14.3) for resuming anticoagulation within 14 days postoperatively and 9.4% (95% CI, 4.1 to 12.8) for not resuming within 14 days, corresponding to a risk ratio of 1.20 (95% CI, 0.67 to 2.36) and risk difference of 1.9% (95% CI, −4.0 to 6.6).
Conclusions
90‐day risk of CSDH recurrence may not differ between early and non‐early resumption of anticoagulation, although early resumption could modestly accelerate recurrence. Allowing for the imprecision of the estimates, these findings provide important insights for clinical decision‐making regarding anticoagulation resumption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
- Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
- Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science, Tokyo, Japan.
- Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka, Japan.
- Department of Clinical Medicine, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
ORCID-Profile: Tomohiro Shinozaki, Koji Kawakami
Zitieren
APA
Anno, T., Fukasawa, T., Shinozaki, T., Takeuchi, M., Yoshida, S., & Kawakami, K. (2024). Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70063
Vancouver
Anno T, Fukasawa T, Shinozaki T, Takeuchi M, Yoshida S, Kawakami K. Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.70063
BibTeX
@article{Anno2024,
author = {Anno, Takayuki and Fukasawa, Toshiki and Shinozaki, Tomohiro and Takeuchi, Masato and Yoshida, Satomi and Kawakami, Koji},
title = {Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
doi = {10.1002/pds.70063}
}
EUVIMED